General Information of the Compound
| Compound ID |
CP0083432
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-isoquinoline
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-((3,4-Dimethoxyphenyl)methyl)-6,7-dimethoxyisoquinoline
1-(3,4-DIMETHOXYBENZYL)-6,7-DIMETHOXYISOQUINOLINE
1-(3,4-Dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline
1-(3,4-Dimethoxybenzyl)-6,7-dimethoxyisoquinoline
1-[(3,4-Dimethoxyphenyl)methyl]6,7-dimethoxyisoquinoline
1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline
1-{[3,4-bis(methyloxy)phenyl]methyl}-6,7-bis(methyloxy)isoquinoline
4-[(6,7-Dimethoxyisoquinolyl)methyl]-1,2-dimethoxybenzene
58-74-2
6,7-Dimethoxy-1-(3,4-dimethoxybenzyl)isoquinoline
6,7-Dimethoxy-1-veratrylisoquinoline
Alapav
Alapav (TN)
Albatran (TN)
Artegodan (TN)
Cardiospan
Cardiospan (TN)
Cardioverina (TN)
Cardoverina
Cepaverin (TN)
Ceraspan
Cerebid
Cerebid (TN)
Cerespan
Cerespan (TN)
Chlorhydrate de papaverine
Delapav
Delapav (TN)
Dicertan (TN)
Dilaves
Dilaves (TN)
Dispamil
Dispamil (TN)
Drapavel
Drapavel (TN)
Durapav
Durapav (TN)
Dynovas
Dynovas (TN)
Forpaven (TN)
Forpavin
Genabid
Houde (TN)
Isoquinoline, 6,7-dimethoxy-1-veratryl-
Isoquinoline, 6,7-dimethoxy-1-veratryl-(8Cl)
Isoquinoline,6,7-dimethoxy-1-veratryl-(8CI)
Mesotina
Mesotina (TN)
Myobid
Myobid (TN)
NSC 136630
Opdensit (TN)
Optenyl (TN)
PAP H
Pameion
Pameion (TN)
Pamelon
Pamelon (TN)
Panergon
Panergon (TN)
Pap-Kaps-150 (TN)
Papacon
Papacon (TN)
Papalease
Papalease (TN)
Papanerin
Papanerin-hcl
Papanerin-hcl (TN)
Papanerine
Papavarine chlorhydrate
Papaverin
Papaverin-Hamelin (TN)
Papaverina
Papaverina [Italian]
Papaverine
Papaverine (BAN)
Papaverine Hcl
Papaverine [BAN]
Papaverine chlorohydrate
Papaverine monohydrochloride
Papaverinium chloride
Papaversan
Papaversan (TN)
Papital TR
Papital TR (TN)
Paptial TR
Paptial TR (TN)
Pavabid
Pavabid (TN)
Pavabid Hp
Pavacap
Pavacap (TN)
Pavacels
Pavacen
Pavacen (TN)
Pavacot
Pavadel (TN)
Pavadyl (TN)
Pavagen
Pavagen (TN)
Pavakey (TN)
Pavarine
Pavased (TN)
Pavatest
Pavatest (TN)
Pavatine
Pavatym
Paverina (TN)
Paverolan
Paverolan (TN)
Paveron
Paveron (TN)
Pavnell
Pavnell (TN)
Qua bid
Qua bid (TN)
RS 47
Ro-Papav
Ro-Papav (TN)
Robaxapap
S-M-R
Spasmo-Nit (TN)
TNP00305
Therapav (TN)
UNII-DAA13NKG2Q
Vasal
Vasal (TN)
Vaso-Pav
Vaso-Pav (TN)
Vasospan (TN)
papaverine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H21NO4
|
||||||||||||||||||
| Molecular Weight |
339.391
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H21NO4/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16/h5-8,10-12H,9H2,1-4H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
XQYZDYMELSJDRZ-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
58-74-2
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05334, ATP-binding cassette sub-family C member 4
Protein ID: PT01875, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Protein ID: PT01798, cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A
Protein ID: PT01730, cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B
Protein ID: PT02805, CREB-binding protein
Protein ID: PT01049, Cytochrome P450 2C19
Clinical Information about the Compound